Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years
Clinical Gastroenterology and Hepatology · 2026-09 · 24 (9) · 2465-2473
DOI: 10.1016/j.cgh.2026.01.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Lin Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese People's Liberation Army (PLA), Beijing, China; Department of Pathology and Hepatology, the Fifth Medical Center of PLA Gen…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND & AIMS: Spontaneous hepatitis B surface antigen (HBsAg) clearance is rare in chronic hepatitis B (CHB). Identifying predictors of antiviral responses is needed. METHODS: We retrospectively identified 1583 treatment-naive children with CHB confirmed by liver biopsy at the Fifth Medical Center of PLA General Hospital from January 2007 to April 2024. Subsequently, 852 patients received antiviral therapy and were followed up every 3 to 6 months. The median follow-up time was 3.5 years. Virological, pathological, and noninvasive tests were performed to explore predictors of antiviral response. RESULTS: Patients in the HBsAg loss group were younger than those in the nonloss group, with a median age of 3 vs 7 years (P < .001). There were 118 (60.8%), 168 (48.3%), 26 (16.7%), and 12 (7.8%) children with CHB who achieved HBsAg clearance among those aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Chinese People's Liberation Army (PLA), Beijing, China; Department of Pathology and Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
- Department of Pathology and Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
- Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
- Department of Pathology and Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China; The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- The Clinical Laboratory, Fifth Medical Center of PLA General Hospital, Beijing, China.
- Department of Pathology and Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China. Electronic address: jmzhao302@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, L., Jiang, L., Zhao, B., Jiang, Y., Liu, S., Li, M., Li, Y., Jiang, Y., Li, M., Wei, H., Bao, C., Niu, J., & Zhao, J. (2026). Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years. Clinical Gastroenterology and Hepatology, 24(9), 2465-2473. https://doi.org/10.1016/j.cgh.2026.01.026
Vancouver
Chen L, Jiang L, Zhao B, Jiang Y, Liu S, Li M, et al. Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years. Clinical Gastroenterology and Hepatology. 2026;24(9):2465-2473. doi:10.1016/j.cgh.2026.01.026
BibTeX
@article{Chen2026,
author = {Chen, Lin and Jiang, Lina and Zhao, Bokang and Jiang, Yue and Liu, Shuhong and Li, Meiling and Li, Yan and Jiang, Yiyun and Li, Meng and Wei, Haiyan and Bao, Chunmei and Niu, Junqi and Zhao, Jingmin},
title = {Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {9},
pages = {2465--2473},
doi = {10.1016/j.cgh.2026.01.026}
}
EUVIMED